{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:36Z","timestamp":1788985176323,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s13346-016-0350-7","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T10:14:49Z","timestamp":1481796889000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis"],"prefix":"10.1007","volume":"7","author":[{"given":"S. N.","family":"Shrotriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Ranpise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. V.","family":"Vidhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,15]]},"reference":[{"key":"350_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2007.00409.x","volume":"49","author":"D Slodownik","year":"2008","unstructured":"Slodownik D, Lee A, Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol. 2008;49:1\u201311.","journal-title":"Australas J Dermatol"},{"key":"350_CR2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.intimp.2007.08.019","volume":"7","author":"MH Han","year":"2007","unstructured":"Han MH, Yoon WK, Lee H, Han SB, Lee K, Park SK, Yang KH, Kim HM, Kang JS. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB\/c mice. Int Immunopharmacol. 2007;7:1651\u20138.","journal-title":"Int Immunopharmacol"},{"key":"350_CR3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejps.2012.12.005","volume":"48","author":"S Bose","year":"2013","unstructured":"Bose S, Kohn BM. Preparation of lipid based nanosystems for topical delivery of quercetin. Eur J Pharm Sci. 2013;48:442\u201352.","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"350_CR4","first-page":"2683","volume":"7","author":"N Sivaranjani","year":"2013","unstructured":"Sivaranjani N, Rao VS, Rajeev G. Role of reactive oxygen species and antioxidants in atopic dermatitis. J Clin Diagn Res. 2013;7(12):2683\u20135.","journal-title":"J Clin Diagn Res"},{"issue":"10","key":"350_CR5","first-page":"1899","volume":"66","author":"JJ Russell","year":"2002","unstructured":"Russell JJ. Topical tacrolimus: a new therapy for atopic dermatitis. Am Family Phys. 2002;66(10):1899\u2013903.","journal-title":"Am Family Phys"},{"key":"350_CR6","first-page":"430","volume":"66","author":"SH Jung","year":"2011","unstructured":"Jung SH, Cho YS, Jun SS, Koo JS, Cheon HG, Shin BC. Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. Pharmazie. 2011;66:430\u20135.","journal-title":"Pharmazie"},{"key":"350_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/752103","author":"Y Yun","year":"2014","unstructured":"Yun Y, Kim K, Choi I, Ko SG. Topical herbal application in the management of atopic dermatitis: a review of animal studies. Mediat Inflamm. 2014; doi: 10.1155\/2014\/752103 .","journal-title":"Mediat Inflamm"},{"issue":"2","key":"350_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2010.12.030","volume":"508","author":"M Ndiayea","year":"2011","unstructured":"Ndiayea M, Philippea C, Mukhtara H, Ahmada N. The grape antioxidant resveratrol for skin disorders: promise, prospects and challenges. Arch Biochem Biophys. 2011;508(2):164\u201370.","journal-title":"Arch Biochem Biophys"},{"key":"350_CR9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/sj.bjc.6601568","volume":"90","author":"S Sale","year":"2004","unstructured":"Sale S, Verschoyle RD, Boocock D, Jones DJL, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher A. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4\u2032-tetramethoxystilbene. Br J Cancer. 2004;90:736\u201344.","journal-title":"Br J Cancer"},{"issue":"2","key":"350_CR10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/2229-5178.131127","volume":"5","author":"VV Pai","year":"2014","unstructured":"Pai VV, Shukla P, Kikkeri NN. Antioxidant in dermatology. Indian Dermatol. 2014;5(2):210\u20134.","journal-title":"Indian Dermatol"},{"key":"350_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1166\/jbn.2007.049","volume":"3","author":"EB Souto","year":"2007","unstructured":"Souto EB, Almeida AJ, Muller RH. Lipid nanoparticles (SLN\u00ae, NLC\u00ae) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol. 2007;3:317\u201331.","journal-title":"J Biomed Nanotechnol"},{"key":"350_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","volume":"59","author":"KM Schafer","year":"2007","unstructured":"Schafer KM, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427\u201343.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"350_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1\u20132):170\u201384.","journal-title":"Int J Pharm"},{"issue":"2","key":"350_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jchromb.2005.12.021","volume":"832","author":"H He","year":"2006","unstructured":"He H, Chen X, Wang G, et al. High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma. J Chromatogr B. 2006;832(2):177\u201380.","journal-title":"J Chromatogr B"},{"key":"350_CR15","doi-asserted-by":"crossref","unstructured":"Ranpise NS, Korabu SS, Ghodake VN. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B: Biointerfaces. 2014;116:81\u20137.","DOI":"10.1016\/j.colsurfb.2013.12.012"},{"key":"350_CR16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","volume":"70","author":"JU Fang","year":"2008","unstructured":"Fang JU, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70:633\u201340.","journal-title":"Eur J Pharm Biopharm"},{"key":"350_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"350_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2006.04.001","volume":"320","author":"MN Padamwar","year":"2006","unstructured":"Padamwar MN, Pokharkar VB. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm. 2006;320:37\u201344.","journal-title":"Int J Pharm"},{"key":"350_CR19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.colsurfb.2009.09.033","volume":"75","author":"EB Souto","year":"2010","unstructured":"Souto EB, Doktorovov\u00e1 S, Ara\u00fajo J, Garcia ML, Rakovsk E. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B\u00a0: Biointerfaces. 2010;75:538\u201342.","journal-title":"Colloids Surf B\u00a0: Biointerfaces"},{"key":"350_CR20","first-page":"205","volume":"1","author":"D Wang","year":"2006","unstructured":"Wang D, Zhao P, Zhang C, Zhang R, Li X, Cui F. Preparation and characterization of total flavones of Hippophae rhamnoides (TFH) solid lipid nanoparticles by heating-ultrasonic dispersion and lyophilization. J Pharm Sci. 2006;1:205\u201312.","journal-title":"J Pharm Sci"},{"issue":"12","key":"350_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2014.938634","volume":"11","author":"R Sonawane","year":"2014","unstructured":"Sonawane R, Harde H, Katariya M, Agrawal S, Jain S. Solid lipid nanoparticles-loaded topical gel containing combination drugs\u00a0: an approach to offset psoriasis. Expert Opin Drug Deliv. 2014;11(12):1\u201315.","journal-title":"Expert Opin Drug Deliv"},{"key":"350_CR22","first-page":"1","volume":"2104","author":"ML Bikkad","year":"2013","unstructured":"Bikkad ML, Nathani AH, Mandlik SK, Shrotriya SN, Ranpise NS. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery. J Liposome Res. 2013;2104:1\u201311.","journal-title":"J Liposome Res"},{"key":"350_CR23","first-page":"313","volume":"52","author":"SA Wissing","year":"2001","unstructured":"Wissing SA, Lippacher A, Muller RH. Investigation on occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci. 2001;52:313\u201324.","journal-title":"J Cosmet Sci"},{"key":"350_CR24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/antiox2040398","volume":"2","author":"PA Kevin","year":"2013","unstructured":"Kevin PA, Saleh MA. Free radical scavenging and antioxidant activities of silymarin components. Antioxidants. 2013;2:398\u2013407.","journal-title":"Antioxidants"},{"issue":"4","key":"350_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/pt070491","volume":"7","author":"PV Pople","year":"2006","unstructured":"Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS Pharm Sci Tech. 2006;7(4):91. E1-E7","journal-title":"AAPS Pharm Sci Tech"},{"issue":"2","key":"350_CR26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejps.2013.03.013","volume":"49","author":"H Vaghasiya","year":"2013","unstructured":"Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013;49(2):311\u201322.","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"350_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","volume":"363","author":"SD Mandawgade","year":"2008","unstructured":"Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm. 2008;363(1\u20132):132\u20138.","journal-title":"Int J Pharm"},{"issue":"2013","key":"350_CR28","first-page":"72","volume":"84","author":"PV Pople","year":"2012","unstructured":"Pople PV, Singh KK. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, part II\u2014in vivo assessment, drug targeting, efficacy and safety in treatment of atopic dermatitis. Eur J Pharm Biopharm. 2012;84(2013):72\u201383.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"350_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13346-015-0261-z","volume":"5","author":"MR Bhalekar","year":"2015","unstructured":"Bhalekar MR, Upadhaya PP, Madgulkar AR. Formulation and evaluation of Adapalene-loaded nanoparticulates for epidermal localization. Drug Deliv Transl Res. 2015;5(6):585\u201395.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"350_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1208\/s12249-012-9908-y","volume":"14","author":"P Wavikar","year":"2013","unstructured":"Wavikar P, Vavia PR. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS PharmSciTech. 2013;14(1):222\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"350_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/02652040400026392","volume":"22","author":"R Dinarvand","year":"2005","unstructured":"Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsul. 2005;22(2):139\u201351.","journal-title":"J Microencapsul"},{"issue":"4","key":"350_CR32","first-page":"1557","volume":"4","author":"AA Kharia","year":"2012","unstructured":"Kharia AA, Singhai AK, Verma R. Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Sci Nanotech. 2012;4(4):1557\u201362.","journal-title":"Int J Pharm Sci Nanotech"},{"key":"350_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/02652049409040440","volume":"11","author":"MY Levy","year":"1994","unstructured":"Levy MY, Schutze W, Fuhrer C, Benita S. Characterization of diazepam submicron emulsion interface: role of oleic acid. J Microencapsul. 1994;11:79\u201392.","journal-title":"J Microencapsul"},{"key":"350_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","volume":"328","author":"J Liu","year":"2007","unstructured":"Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191\u20135.","journal-title":"Int J Pharm"},{"key":"350_CR35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/mp200541r","volume":"9","author":"SS Patil","year":"2012","unstructured":"Patil SS, Venugopal E, Bhat S, Mahadik KR, Paradkar AR. Probing influence of mesophasic transformation on performance of self-emulsifying system: effect of ion. Mol Pharm. 2012;9:318\u201324.","journal-title":"Mol Pharm"},{"issue":"2","key":"350_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1208\/s12249-010-9414-z","volume":"11","author":"M Shah","year":"2010","unstructured":"Shah M, Pathak K. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design. AAPS Pharm Sci Tech. 2010;11(2):489\u201396.","journal-title":"AAPS Pharm Sci Tech"},{"key":"350_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(02)00130-3","volume":"55","author":"MA Schubert","year":"2003","unstructured":"Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles\u2014evaluation of the method and process parameters. Eur J Pharm Biopharm. 2003;55:125\u201331.","journal-title":"Eur J Pharm Biopharm"},{"key":"350_CR38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.addr.2007.04.013","volume":"59","author":"H Bunjes","year":"2007","unstructured":"Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 2007;59:379\u2013402.","journal-title":"Adv Drug Deliv Rev"},{"key":"350_CR39","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0142-9612(02)00578-1","volume":"24","author":"D Hou","year":"2003","unstructured":"Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003;24:1781\u20135.","journal-title":"Biomaterials"},{"issue":"1(2)","key":"350_CR40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1(2)):170\u201384.","journal-title":"Int J Pharm"},{"key":"350_CR41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/026520499289310","volume":"16","author":"C Freitas","year":"1999","unstructured":"Freitas C, Muller RH. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J Microencapsul. 1999;16:59\u201371.","journal-title":"J Microencapsul"},{"key":"350_CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","volume":"47","author":"C Freitas","year":"1999","unstructured":"Freitas C, M\u00fcller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN\u2122) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 1999;47:125\u201332.","journal-title":"Eur J Pharm Biopharm"},{"key":"350_CR43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(01)00755-4","volume":"224","author":"YY Wang","year":"2001","unstructured":"Wang YY, Hong CT, Chiu WT, Fang JY. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm. 2001;224:89\u2013104.","journal-title":"Int J Pharm"},{"key":"350_CR44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1211\/jpp.59.8.0002","volume":"59","author":"V Sanna","year":"2007","unstructured":"Sanna V, Gavini E, Cossu M, et al. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol. 2007;59:1057\u201364.","journal-title":"J Pharm Pharmacol"},{"key":"350_CR45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0939-6411(99)00075-2","volume":"49","author":"V Jenning","year":"2003","unstructured":"Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2003;49:211\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"350_CR46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0378-5173(02)00220-X","volume":"242","author":"SA Wissing","year":"2002","unstructured":"Wissing SA, Muller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm. 2002;242:377\u201389.","journal-title":"Int J Pharm"},{"key":"350_CR47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","volume":"56","author":"G Cevc","year":"2004","unstructured":"Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev. 2004;56:675\u2013711.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0350-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-016-0350-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-016-0350-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T11:50:31Z","timestamp":1568634631000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-016-0350-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1007\/s13346-016-0350-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,15]]}}}